Healthcare & Medical Investment Corporation
Health Care & Medical Investment Corporation Investigation Report: Financial Summary for the July 2026 Fiscal Period
For the July 2026 term, operating revenue is 2,659 million yen and net income is 1,015 million yen, with total distributions per unit of 3,174 yen. For the January–July 2027 period, expected operating revenue is around 3,595 million yen; as a condition for per-unit distributions, compressed reserve funds will be utilized. Acquisition and recognition of 14 new assets are planned, with ongoing asset acquisitions to continue.
Key Figures
- Distributions: 3,174 yen per investment unit (this period)
- Total issued investment units: 452,358 units (as of September 2026)
- Interest-bearing debt balance: 55,700 million yen (end of January 2027 / end of July period forecast)
AI要約
Overview of results
For the fiscal year ended July 2026, total assets amount to 88,498 hundred million yen and net assets to 38,512 hundred million yen, with operating revenue of 2,659 hundred million yen, operating income of 1,341 hundred million yen, ordinary income of 1,016 hundred million yen, and net income attributable to owners of parent of 1,015 hundred million yen. Distributions per unit are 3,174 yen, with zero excess distribution. Looking ahead, expansion of operating assets including newly acquired assets is anticipated for the January and July 2027 periods.
Capital policy and funding trends
From August 2026 onward, a public offering of new investment units was conducted, and at the end of the period the total number of issued investment units reached 452,358 units, with total contributed capital of 46,861 hundred million yen. For the assets to be acquired in January 2027, financing of about 111 billion yen is planned, and the total borrowings will be managed assuming interest-bearing debt of 55,700 hundred million yen.
Healthcare & Medical Investment Corporation
Company overview · Stock price · Financial data · All IR
